Skip to content

Clinical trials

Observational Lung Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Country / region: Belgium Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20092
20101
20111
20121
20131
20142
20153
20161
20172
20181
20191
20201
20211
20221
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting5
Unknown status5
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Hasselt University4
European Lung Cancer Working Party2
Medical University of Vienna2
AZ Delta1
Amgen1
Asylia Diagnostics BV1
Biobizkaia Health Research Institute1
Bristol-Myers Squibb1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms27
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Ovarian Neoplasms5
Colorectal Neoplasms4
Neoplasms4
Urinary Bladder Neoplasms4
Pancreatic Neoplasms3
Prostatic Neoplasms3
Endocrine Gland Neoplasms2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.